Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Actuate Therapeutics, Inc. (ACTU) had Weighted-Average Shares Outstanding (Diluted) of 21.02M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-4.55M |
|
-- |
|
-- |
|
$4.69M |
|
$-4.69M |
|
$0.13M |
|
$-4.55M |
|
$-4.55M |
|
$-4.55M |
|
$-4.55M |
|
$-4.55M |
|
$-4.55M |
|
$-4.69M |
|
$-4.69M |
|
21.02M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
21.02M |
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$13.64M |
|
-- |
|
$0.39M |
|
$14.04M |
|
$5.71M |
|
-- |
|
$0.41M |
|
$6.11M |
|
$7.92M |
|
$7.92M |
|
$7.92M |
|
23.25M |
|
| Cash Flow Statement Financials | |
$-19.21M |
|
-- |
|
$23.72M |
|
$8.64M |
|
$13.16M |
|
$4.52M |
|
$6.05M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.39 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.21M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-57.47% |
|
-57.47% |
|
-32.45% |
|
-57.47% |
|
$0.34 |
|
$-0.91 |
|
$-0.91 |
|